Air Products and Chemicals Inc

APD remains in a Stage 2 advancing uptrend, carving sequential higher highs and lows while holding above rising short-term EMAs. Momentum readings are neutral-to-modestly bullish with price tightly tracking above the 9- and 20-day EMAs, offering room for continuation above the ~308 resistance zone. The Stable strategy favors patient engagement, highlighting shallow pullbacks toward the 20 EMA (~305) as preferred entries. Overall conditions support immediate participation, with key support levels protecting against broader pullbacks.

• ↑Q3 2026 EPS $3.47, +12% YoY, driven by volume growth and strong pricing.
• ↑Q3 revenue $2.7B (+5% YoY) and operating income $691M (+9% YoY).
• ↓Helium market weakness could reduce EPS by 4%–5% in FY26.